Hebrew
Home
About DTL
Placental protein 13
News & Events
Library
Contact Us
Home
» Site Map
Site Map
About DTL
Our Team
Directors
Directors
Dr. Hamutal Meiri
Mrs Cheli Aflalo-Karpel
Mr. Ron Karie
Placental protein 13
PP 13 Test
Preeclampsia
News & Events
Press Releases
Perkin Elmer Expands Maternal Health Technology for Early Identification of Patients at Risk for Preeclampsia
Grant Life Sciences ('Grant') enters into a Memorandum of Understanding with Diagnostic Technologies Ltd. ('DTL') to develop and commercialize Grant's cervical cancer-diagnostic technology
Events
The annual meeting of the Israeli Society of Ultrasound in Obsterics and Gynecology
The annual meeting of the Israeli Society For Maternal – Fetal Medicine
Biomed Israel 2006
Library
Articles
Articles
Articles
PP13 as an early marker for preeclampsia
First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction
A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler Ultrasound
First-trimester maternal serum PP-13, Papp-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia
Second-trimester Uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia
Placental protein 13 (PP-13): effects on cultured trophoblasts and its detection in human body fluids in normal and pathological pregnancies
Functional analyses of placental protein 13/galectin-13
Contact Us
Copyright © 2005 Diagnostic Technologies Ltd. All rights reserved.
Site Map
Created by
Catom.
